Literature DB >> 12520756

T1-weighted hyperintensity in basal ganglia at brain magnetic resonance imaging: are different pathologies sharing a common mechanism?

Elena Herrero Hernandez1, Maria Consuelo Valentini, Gianluigi Discalzi.   

Abstract

Basal ganglia bilateral symmetric hyperintensity in T1-weighted sequences at magnetic resonance imaging (MRI) is recognized to be due to the presence of manganese deposits. This abnormal finding has been reported in occupational exposures, liver cirrhosis and total parenteral nutrition with unbalanced solutions. However, the same imaging is often observed "by chance" in brain MRIs of patients not belonging to these groups. In order to better understand which are the clinical conditions coexisting with such findings, we decided to study systematically patients which showed this kind of imaging, focusing on their manganese and iron status, as it is known that these two metals have similar properties and that iron-deficiency can competitively increase manganese absorption. The 20 patients studied underwent clinical evaluation and the following laboratory tests: whole blood iron and manganese, hemoglobin, plasma iron, transferrin and ferritin. The neuroradiologic evaluation was integrated by pallidal index calculation, in order to provide a semi-quantitative esteem of the hyperintensity. The patients could be classified into four subgroups: Parkinsonism, anemia, cirrhosis, central nervous system tumors. In 18 out of 20 cases, we found abnormalities in iron and/or manganese-related values. Particularly, iron-deficiency seems to be frequent among patients showing brain MRI abnormalities compatible with manganese deposits in basal ganglia. This observation suggests that iron-deficiency could be an important risk factor for manganese-induced neurotoxicity and should, therefore, be accurately considered and treated.

Entities:  

Mesh:

Year:  2002        PMID: 12520756     DOI: 10.1016/S0161-813X(02)00016-5

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  8 in total

Review 1.  Acquired hepatocerebral degeneration.

Authors:  Joseph Ferrara; Joseph Jankovic
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

Review 2.  Manganese and its role in Parkinson's disease: from transport to neuropathology.

Authors:  Michael Aschner; Keith M Erikson; Elena Herrero Hernández; Elena Herrero Hernández; Ronald Tjalkens
Journal:  Neuromolecular Med       Date:  2009       Impact factor: 3.843

3.  Exposure to Mn/Zn ethylene-bis-dithiocarbamate and glyphosate pesticides leads to neurodegeneration in Caenorhabditis elegans.

Authors:  Rekek Negga; David A Rudd; Nathan S Davis; Amanda N Justice; Holly E Hatfield; Ana L Valente; Anthony S Fields; Vanessa A Fitsanakis
Journal:  Neurotoxicology       Date:  2011-03-03       Impact factor: 4.294

Review 4.  Influence of iron metabolism on manganese transport and toxicity.

Authors:  Qi Ye; Jo Eun Park; Kuljeet Gugnani; Swati Betharia; Alejandro Pino-Figueroa; Jonghan Kim
Journal:  Metallomics       Date:  2017-08-16       Impact factor: 4.526

Review 5.  Altered modulation of motor activity by group I metabotropic glutamate receptors in the nucleus accumbens in hyperammonemic rats.

Authors:  Omar Cauli; Marta Llansola; Regina Rodrigo; Nisrin El Mlili; Mohammed Errami; Vicente Felipo
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

6.  The Impact of the hyperacid Ijen Crater Lake. Part II: A total diet study.

Authors:  Alex Heikens; Budi Widianarko; Inge C Dewi; Jan L M de Boer; Willem Seinen; Kees van Leeuwen
Journal:  Environ Geochem Health       Date:  2005-09       Impact factor: 4.609

7.  Hepatic cirrhosis, dystonia, polycythaemia and hypermanganesaemia--a new metabolic disorder.

Authors:  Karin Tuschl; Philippa B Mills; Howard Parsons; Marian Malone; Darren Fowler; Maria Bitner-Glindzicz; Peter T Clayton
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

Review 8.  Manganese-Induced Parkinsonism and Parkinson's Disease: Shared and Distinguishable Features.

Authors:  Gunnar F Kwakye; Monica M B Paoliello; Somshuvra Mukhopadhyay; Aaron B Bowman; Michael Aschner
Journal:  Int J Environ Res Public Health       Date:  2015-07-06       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.